Retatrutide, Amycretin, Survodutide, VK2735, and MariTide are among the most watched pipeline assets heading into 2026 because each represents a different answer to the same commercial question: what comes after Ozempic, Wegovy, Mounjaro, and Zepbound
10.1016/j.numecd.2016.01.011 32
Two practical points that the numbers alone dont capture: Add water slowly, down the vial wall
TLR2 agonists significantly increase the proliferation of epithelial cell lines through multiple protein kinase pathways, and such experimental results were further confirmed by experiments in TLR2-deficient mice, where epithelial value-added was reduced in TLR2-deficient mice (46), and this effect would potentially impact on esophageal mucosal injury and repair
Eli Lilly partnered with Fauna Bio to explore novel targets beyond GLP-1s, looking for ways to help humans maintain healthy metabolism during weight loss
The truth is, once the medication stops, the weight will likely creep back on if nothing else changes (as seen in studies)